P53 expression in invasive pancreatic adenocarcinoma and precursor lesions

Malaysian Journal of Pathology

Volumn 33, Issue 2, 2011, Pages 89-94

  Norfadzilah, M Y ^a   Pailoor, Jayalakshmi ^a   Retneswari, M ^a   Chinna, K ^a   Noor Laili, M M ^b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b Selayang Hospital   (Malaysia)

Author keywords

Immunoperoxidase; Malignancy; p53; Pancreas

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER GRADING; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; GENE INACTIVATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALIGNANT TRANSFORMATION; PANCREAS ADENOCARCINOMA; PANCREAS ADENOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR DIFFERENTIATION; UPREGULATION;

CARCINOMA IN SITU; CARCINOMA, PANCREATIC DUCTAL; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM GRADING; PANCREATIC NEOPLASMS; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84855322220     PISSN: 01268635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Cubilla AL, Fitzgerald PJ. Cancer of the exocrine pancreas: The pathologic aspects. Ca Cancer J Clin 1985, 35:2-18.
2. Hruban RH, Fukushima N. Pancreatic adenocarcinoma: update on surgical pathology of carcinomas of ductal origin and PanINs. Mod Pathol 2007, 20 (suppl 1): S61-70.
3. Japan Pancreas Society. Pancreatic-Cancer registry report 2007. Suizo 2007; 21:1-42.
4. Lim GCC, Halima Y, editors. Second Report of the National Cancer Registry. Cancer incidence in Malaysia 2003. National Cancer Registry, Kuala Lumpur 2004.
5. Andea A, Sarkar F, Adsay VN. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcionoma. Mod Pathol 2003; 16: 996-1006.
6. Cubilla AL, Fitzgerald PJ. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res 1976; 36:2690-8.
7. Kozuka S, Sassa R, Taki T, et al. Relation of pancreatic duct hyperplasia to carcinoma. Cancer 1979; 43:1418-28.
8. Hruban RH, Takaori K, Klimstra DK, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary neoplasms. Am J Surg Pathol 2004;28(8):977-87.
9. Zamboni G, Kloppel G, Hruban RH, Longnecker DS, Adler G. In: Hamilton S.R, Aaltonen L.A, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumors of the digestive system. IARC Press. Lyon 2000. 234-6.
10. Hermanova M, Trna J, Nenutil R, Dite P, Kala Z. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions. Eur J Gastroenterol Hepatol 2008; 20:732-9.
11. Biankin AV, Kench JG, Biankin SA, et al. Pancreatic intraepithelial neoplasia in association with intraductal papillary mucinous neoplasms of the pancreas: implications for disease progression and recurrence. Am J Surg Pathol 2004; 28:1184-92.
12. Abe K, Suda K, Arakawa A, et al. Different patterns of p16NK4A and p53 protein expression in intraductal papillary mucinous neoplasm and pancreatic intraepithelial neoplasia. Pancreas 2007; 34:85-91